(Q39881304)

15 September 2017

title

Short and long-term tumor cell responses to Aurora kinase inhibitors (English)

1 reference

15 September 2017

Megan R Dreier

1

1 reference

15 September 2017

Aaron Z Grabovich

series ordinal

2

1 reference

15 September 2017

Jamie D Katusin

series ordinal

3

1 reference

15 September 2017

William R Taylor

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

20 February 2009

1 reference

Experimental Cell Research

15 September 2017

published in

1 reference

15 September 2017

volume

315

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

1085-1099

1 reference

Perspective: defects in cell cycle control and cancer

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Advances in mitotic inhibitors for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Peripheral neuropathy induced by microtubule-stabilizing agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Dawn of Aurora kinase inhibitors as anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora kinase inhibitors: a new class of targeted drugs in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora-kinase inhibitors as anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Targeting Aurora kinases for the treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

The chromosomal passenger complex: guiding Aurora-B through mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Chromosomal passengers: the four-dimensional regulation of mitotic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Centrosome maturation: Aurora lights the way to the poles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora C is directly associated with Survivin and required for cytokinesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Cell cycle-dependent expression and centrosome localization of a third human aurora/Ipl1-related protein kinase, AIK3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Validating Aurora B as an anti-cancer drug target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Evolutionary relationships of Aurora kinases: implications for model organism studies and the development of anti-cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Mechanisms of G2 arrest in response to overexpression of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Caffeine inhibits the checkpoint kinase ATM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Cell cycle checkpoint signaling through the ATM and ATR kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a "tetraploidy checkpoint".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

Molecular basis of drug resistance in aurora kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.008

10.1016/J.YEXCR.2009.02.008

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference